Cargando…
Urinary levels of pro-fibrotic transglutaminase 2 (TG2) may help predict progression of chronic kidney disease
Renal clinical chemistry only detects kidney dysfunction after considerable damage has occurred and is imperfect in predicting long term outcomes. Consequently, more sensitive markers of early damage and better predictors of progression are being urgently sought, to better support clinical decisions...
Autores principales: | Da Silva Lodge, Michelle, Pullen, Nick, Pereira, Miguel, Johnson, Timothy S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765645/ https://www.ncbi.nlm.nih.gov/pubmed/35041708 http://dx.doi.org/10.1371/journal.pone.0262104 |
Ejemplares similares
-
Discovery and
Characterization of PROTACs Targeting
Tissue Transglutaminase (TG2)
por: Valdivia, Andres, et al.
Publicado: (2023) -
Increased Osteoclastogenesis in Absence of TG2 Is Reversed by Transglutaminase Inhibition—Evidence for the Role for TG1 in Osteoclast Formation
por: Ebrahimi Samani, Sahar, et al.
Publicado: (2023) -
Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease
por: Martucciello, Stefania, et al.
Publicado: (2020) -
Tissue Transglutaminase (TG2)-Induced Inflammation in Initiation, Progression, and Pathogenesis of Pancreatic Cancer
por: Mehta, Kapil, et al.
Publicado: (2011) -
Effect of transglutaminase 2 (TG2) deficiency on atherosclerotic plaque stability in the apolipoprotein E deficient mouse
por: Williams, Helen, et al.
Publicado: (2010)